Page 11 - CIMA OCS Workbook May 2019 - Day 1 Tasks
P. 11

MANAGEMENT ACCOUNTING (P1) ‐ PRACTICE TASKS


                  EXERCISE 3 (RISK)


                  UPDATE
                  At a recent Board meeting of VitaMine, Suresh Patel (MD) put forward a proposal to make and
                  sell a new liquid supplement containing elderberry, zinc and astragalus. He explained that
                  elderberry has been used traditionally to maintain health and well‐being, astragalus is an herb
                  that has been included to support a healthy immune system response to seasonal challenges and
                  zinc has been added to promote normal immune system function. The new product would be
                  aimed at children, who would take a spoonful each day like a medicine.

                  Having considered a range of methods, strategies and investment vehicles, the Board have
                  decided that selling via a single major retailer, VitaSite, would be less risky than other alternatives
                  and would allow VitaMine to learn more about consumer response and trends before committing
                  to a larger investment. The Board is now considering the specific details of the proposal. To help
                  make the decision an external consultancy has been asked to prepare a report on the financial
                  implications of the investment. This report can be found in the reference materials below.

                  TRIGGER
                  This morning you received the following email from Juliette Goh (FD):


                  From: Juliette Goh (FD)
                  Subject: Elderberry Supplement


                  As you may have heard, the Board are considering a proposal to make and sell a new elderberry
                  based supplement for children. To assist the decision making process Yamazaki and Co, a firm of
                  consultants, have been asked to do some preliminary calculations. Extracts of their report are
                  given in the attachment to this email (see reference materials).


                  I have a meeting with the Board to discuss whether or not to proceed with the proposal and the
                  main emphasis will be on risk and return as far as the financial aspects are concerned. I am
                  concerned that some Board members will not understand the report but Ashok Kumar and I are
                  tied up with auditors today, so would appreciate you preparing me something on the following
                  that I could use to communicate to the Board:

                        Can you start by outlining why we consider risk as well as return and what each of these
                         terms means.
                        Which measures suggested by the consultants give an indication of the project “return”
                         and how the Board should interpret them.
                        Similarly, which measures give an indication of the project “risk” and how the Board
                         should interpret them.
                        Finally, your recommendations ‐ do you think the risks are reasonable? Have all risks
                         been accounted for here?

                  Can you prepare me a draft report addressing the above issues.




                  TASK

                  Prepare the report requested by Juliette.
                                                                               (Time allocation: 40 minutes)

                  KAPLAN PUBLISHING                                                                    29
   6   7   8   9   10   11   12   13   14   15   16